Literature DB >> 10259

Blastogenic response of human lymphocytes to oral bacterial antigens: comparison of individuals with periodontal disease to normal and edentulous subjects.

M R Patters, R J Genco, M J Reed, P A Mashimo.   

Abstract

Cell-mediated immunity in humans to antigens derived from oral plaque bacteria was investigated by using the lymphocyte blastogenesis assay. Subjects with varying severities of periodontal disease including normal, gingivitis, periodontitis, and edentulous were compared. Mononuclear leukocytes were separated from peripheral blood and cultured with antigens prepared by sonication of Actinomyces viscosus (AV), Actinomyces naeslundii (AN), Veillonella alcalescens (VA), Leptotrichia buccalis (LB), Bacteroides melaninogenicus (BM), and homologous dental plaque (DP). The lymphocyte response of subjects with gingivitis or periodontitis was significantly greater than that of normal subjects to antigens of AV, AN, and DP, but did not differ from the response of edentulous subjects. Periodontitis subjects were significantly more reactive than edentulous and normal subjects in response to VA, LB, and BM. These findings suggest that the tested gram-negative bacteria and the host response they evoke are associated with advanced periodontal destruction.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10259      PMCID: PMC415516          DOI: 10.1128/iai.14.5.1213-1220.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Synergistic effects on DNA synthesis of phytohemagglutinin or concanavalin A and lipopolysaccharide in human peripheral blood lymphocytes.

Authors:  J R Schmidtke; J S Najarian
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

2.  PERIODONTAL DISEASE IN PREGNANCY. II. CORRELATION BETWEEN ORAL HYGIENE AND PERIODONTAL CONDTION.

Authors:  J SILNESS; H LOE
Journal:  Acta Odontol Scand       Date:  1964-02       Impact factor: 2.331

3.  PERIODONTAL DISEASE IN PREGNANCY. I. PREVALENCE AND SEVERITY.

Authors:  H LOE; J SILNESS
Journal:  Acta Odontol Scand       Date:  1963-12       Impact factor: 2.331

4.  A system of classification and scoring for prevalence surveys of periodontal disease.

Authors:  A L RUSSELL
Journal:  J Dent Res       Date:  1956-06       Impact factor: 6.116

5.  Immediate hypersensitivity and periodontal disease.

Authors:  R Nisengard
Journal:  J Periodontol       Date:  1974-05       Impact factor: 6.993

6.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

7.  Human lymphoproliferative reaction to saliva and dental plaque-deposits: an in vitro correlation with periodontal disease.

Authors:  J E Horton; S Leikin; J J Oppenheim
Journal:  J Periodontol       Date:  1972-09       Impact factor: 6.993

8.  Antibody-mediated effects on the periodontium.

Authors:  R J Genco; P A Mashimo; G Krygier; S A Ellison
Journal:  J Periodontol       Date:  1974-05       Impact factor: 6.993

9.  Blastogenic response of human lymphocytes to oral bacterial antigens: characterization of bacterial sonicates.

Authors:  M J Reed; M R Patters; P A Mashimo; R J Genco; R J Levine
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

10.  Importance of Actinomyces and certain gram-negative anaerobic organisms in the transformation of lymphocytes from patients with periodontal disease.

Authors:  J J Baker; S P Chan; S S Socransky; J J Oppenheim; S E Mergenhagen
Journal:  Infect Immun       Date:  1976-05       Impact factor: 3.441

View more
  23 in total

1.  A novel factor isolated from Actinobacillus actinomycetemcomitans stimulates mouse B cells and human peripheral blood mononuclear cells.

Authors:  S J Jeong; S T Yee; W S Jo; S H Yu; S H Lee; Y J Lim; Y H Yoo; J M Kim; J D Lee; M H Jeong
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

Review 2.  Serological responses to antigens of Bacteroidaceae.

Authors:  T Hofstad
Journal:  Microbiol Rev       Date:  1979-03

3.  Cell-mediated immune response to bacterial products in human tonsils and peripheral blood lymphocytes.

Authors:  M M Drucker; Y Agatsuma; I Drucker; E Neter; J Bernstein; P L Ogra
Journal:  Infect Immun       Date:  1979-02       Impact factor: 3.441

4.  Effects of endogenous and exogenous inhibitors on the incorporation of labeled precursors into DNA by human mononuclear cells.

Authors:  T J Sims; R C Page
Journal:  Infect Immun       Date:  1982-11       Impact factor: 3.441

5.  Blastogenic response of human lymphocytes to oral bacterial antigens: characterization of bacterial sonicates.

Authors:  M J Reed; M R Patters; P A Mashimo; R J Genco; R J Levine
Journal:  Infect Immun       Date:  1976-11       Impact factor: 3.441

6.  The role of TG lymphocytes in cell-mediated immunity in patients with periodontal disease.

Authors:  L Ivanyi; B Topic; P M Lydyard
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

7.  In vitro lymphocyte blastogenic responses and titers of humoral antibodies from periodontitis patients to oral spirochete isolates.

Authors:  D F Mangan; B E Laughon; B Bower; D E Lopatin
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

8.  Cell-associated levan of Actinomyces viscosus.

Authors:  T N Warner; C H Miller
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

9.  Effects of metabolic inhibitors on extracellular fructosyltransferase production in Actinomyces viscosus.

Authors:  W Chak; H K Kuramitsu
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

10.  Longitudinal effects of clinical therapy and the edentulous state on the transformation of lymphocytes from patients with severe periodontitis.

Authors:  J J Baker; W E Wright; S P Chan; J J Oppenheim
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.